Report cover image

Japan In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Major Deals, Trends and Recent Developments – Forecast to 2028

Publisher iGate Research PVT LTD.
Published Jun 14, 2023
Length 200 Pages
SKU # IGR18012858

Description

Japan In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Major Deals, Trends and Recent Developments – Forecast to 2028


Japan In Vitro Diagnostics (IVD) market is predicted to surpass US$ 5.5 Billion by 2028. Japan is one of the leading clinical laboratory markets in the Asia–Pacific region, and one of the largest markets for in vitro diagnostics (IVD) in the world. Japan is facing the challenges of fighting with infectious disease including HBV, TB, HCV, and HIV, as well as various chronic disease and cancer. The population of Japan is aging rapidly. For instance, as of November 2022, close to 36.5 million people in Japan were estimated to be within the age group 65 and over. Thus, Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.

Japan In Vitro Diagnostics (IVD) Market – Recent Developments
  • In April 2023, Oxford Nanopore Technologies plc, and bioMérieux SA teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
  • In December 2022, bioMérieux announced the CE-marking of VIDAS KUBE, the next generation automated immunoassay system for the VIDAS range.
  • In July 2022, DiaCarta Inc., a molecular diagnostics company announced that the company has received CE-IVD Mark for its newly developed QuantiVirus SARS-CoV-2 & Flu A/B test.
By Segment Japan IVD Market and Forecast – Key Takeaway
  • On segment basis, Genetic Testing and Clinical Chemistry are the leading segment of the Japan IVD market.
  • Immunoassay stands at the 3rd leading spot in the Japan in vitro diagnostics market.
  • Tumor Marker and Hematology segments are competing closely with each other to grab maximum share of the pie.
  • Infectious disease segment contributed over 10 percent to the Japan IVD market in 2022.
Japan IVD Market – Company Analysis
  • In the Japan IVD market, Roche Diagnostics is the leader, followed by Sysmex Corporation.
  • Abbott Laboratories, Thermo Fisher Scientific Inc., and Danaher Corporation are the other top three players in the Japan IVD market.
  • In the diagnostics business, Abbott will focus on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing system.
  • In April 2023, bioMérieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System.
iGATE RESEARCH report titled “Japan In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Major Deals, Trends and Recent Developments – Forecast to 2028” provides a comprehensive assessment of the fast–evolving, high–growth Japan IVD Market.

This 200 Page report with 42 Figures and 4 Tables has been analyzed from 8 View Points:

1) Japan In-Vitro Diagnostics (IVD) Market and Forecast (2008 – 2028)
2) Japan IVD Market Share and Forecast (2008 – 2028)
3) Japan IVD Market & Forecast – By Segment (2008 – 2028)
4) Japan IVD Market & Forecast – Company Sales Analysis (2014 – 2028)
5) Japan IVD Market – Major Deals
6) Japan IVD Market – Recent Developments
7) Registration for In Vitro Diagnostic Devices in Japan
8) Japan IVD Market - Drivers & Challenges

Japan IVD Market – By Segment

1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. SMBG
5. Tumor Marker
6. Immunoassay
7. Infectious Disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others

Japan IVD Sales & Forecast – By Company

1. Roche Diagnostics
2. Abbott Laboratories
3. Danaher Corporation
4. Biomerieux
5. Sysmex Corporation
6. Bio-Rad Laboratories, Inc
7. Becton Dickinson Company
8. Thermo Fisher Scientific Inc.
9. Others

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies:

Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies:

Printable and Non–printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

200 Pages
1. Executive Summary
2. Japan In–Vitro Diagnostics (IVD) Market and Market Share Analysis – Forecast to 2028
2.1 Japan IVD Market and Forecast (2008 – 2028)
2.2 By Segment – Japan IVD Market Share and Forecast (2008 – 2028)
2.3 By Company – Japan IVD Share and Forecast (2015 – 2028)
3. Japan IVD – Segments Wise Market and Forecast (2008 – 2028)
3.1 Urine & Feces Market and Forecast
3.2 Hematology Market and Forecast
3.3 Clinical Chemistry Market and Forecast
3.4 SMBG Market and Forecast
3.5 Tumor Marker Market and Forecast
3.6 Immunoassay Market and Forecast
3.7 Infectious Disease Market and Forecast
3.8 Microbiology Market and Forecast
3.9 Pathology Market and Forecast
3.10 Genetic Testing Market and Forecast
3.11 Others Market and Forecast
4. Japan IVD Market – Company Wise Sales Analysis (2014 – 2028)
4.1 Roche Diagnostics
4.1.1 Business Overview
4.1.2 Roche Diagnostics – Japan IVD Sales and Forecast
4.1.3 Recent Developments
4.2 Abbott Laboratories
4.2.1 Business Overview
4.2.2 Abbott Laboratories – Japan IVD Sales and Forecast
4.2.3 Recent Developments
4.3 Danaher Corporation
4.3.1 Business Overview
4.3.2 Danaher Corporation – Japan IVD Sales and Forecast
4.3.3 Recent Initiatives/ Strategy/ Developments
4.4 Biomerieux
4.4.1 Business Overview
4.4.2 Biomerieux – Japan IVD Sales and Forecast
4.4.3 Recent Initiatives/ Strategy/ Developments
4.5 Sysmex Corporation
4.5.1 Business Overview
4.5.2 Sysmex Corporation – Japan IVD Sales and Forecast
4.5.3 Recent Initiatives/ Strategy/ Developments
4.6 Bio–Rad Laboratories, Inc
4.6.1 Business Overview
4.6.2 Bio–Rad Laboratories, Inc – Japan IVD Sales and Forecast
4.6.3 Recent Initiatives/ Strategy/ Developments
4.7 Becton Dickinson and Company
4.7.1 Business Overview
4.7.2 Becton Dickinson and Company – Japan IVD Sales and Forecast
4.7.3 Recent Initiatives/ Strategy/ Developments
4.8 Thermo Fisher Scientific Inc.
4.8.1 Business Overview
4.8.2 Thermo Fisher Scientific Inc. – Japan IVD Sales and Forecast
4.8.3 Recent Initiatives/ Strategy/ Developments
4.9 Others – Japan IVD Sales and Forecast
5. Japan IVD Market – Major Deals
5.1 2023
5.2 2022
5.3 2021
5.4 2020
5.5 2019
6. In-Vitro Diagnostics (IVD) Market - Recent Developments
7. Japan IVD Market – Driving Factors
7.1 Technology Advancement Spurring the IVD Market
7.2 Increasing Geriatric Population
7.3 High Prevalence of Chronic and Infectious Diseases
8. Japan IVD Market – Challenges
8.1 Cumbersome Reimbursement Procedure
8.2 Stringent Regulatory Framework
8.3 Operational Barriers Faced in Conducting Diagnostic Tests
List of Figures:
Figure 2-1: Japan – IVD Market (Million US$), 2008 – 2022
Figure 2-2: Japan – Forecast for IVD Market (Million US$), 2023 – 2028
Figure 3-1: Japan – Urine & Feces Market (Million US$), 2008 – 2022
Figure 3-2: Japan – Forecast for Urine & Feces Market (Million US$), 2023 – 2028
Figure 3-3: Japan – Hematology Market (Million US$), 2008 – 2022
Figure 3-4: Japan – Forecast for Hematology Market (Million US$), 2023 – 2028
Figure 3-5: Japan – Clinical Chemistry Market (Million US$), 2008 – 2022
Figure 3-6: Japan – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
Figure 3-7: Japan – SMBG Market (Million US$), 2008 – 2022
Figure 3-8: Japan – Forecast for SMBG Market (Million US$), 2023 – 2028
Figure 3-9: Japan – Tumor Marker Market (Million US$), 2008 – 2022
Figure 3-10: Japan – Forecast for Tumor Marker Market (Million US$), 2023 – 2028
Figure 3-11: Japan – Immunoassay Market (Million US$), 2008 – 2022
Figure 3-12: Japan – Forecast for Immunoassay Market (Million US$), 2023 – 2028
Figure 3-13: Japan – Infectious Disease Market (Million US$), 2008 – 2022
Figure 3-14: Japan – Forecast for Infectious disease Market (Million US$), 2023 – 2028
Figure 3-15: Japan – Microbiology Market (Million US$), 2008 – 2022
Figure 3-16: Japan – Forecast for Microbiology Market (Million US$), 2023 – 2028
Figure 3-17: Japan – Pathology Market (Million US$), 2008 – 2022
Figure 3-18: Japan – Forecast for Pathology Market (Million US$), 2023 – 2028
Figure 3-19: Japan – Genetic Testing Market (Million US$), 2008 – 2022
Figure 3-20: Japan – Forecast for Genetic Testing Market (Million US$), 2023 – 2028
Figure 3-21: Japan – Others Market (Million US$), 2008 – 2022
Figure 3-22: Japan – Forecast for Others Market (Million US$), 2023 – 2028
Figure 4-1: Roche Diagnostics – Japan IVD Sales (Million US$), 2012 – 2022
Figure 4-2: Roche Diagnostics – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-3: Abbott Laboratories – Japan IVD Sales (Million US$), 2012 – 2022
Figure 4-4: Abbott Laboratories – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-5: Danaher Corporation – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-6: Danaher Corporation – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-7: biomerieux – Japan IVD Sales (Million US$), 2015 – 2022
Figure 4-8: Biomerieux – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-9: Sysmex Corporation – Japan IVD Sales (Million US$), 2010 – 2022
Figure 410: Sysmex Corporation – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-11: Bio–Rad Laboratories, Inc – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-12: Bio–Rad Laboratories, Inc – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-13: Becton Dickinson and Company – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-14: Becton Dickinson and Company – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-15: Thermo Fisher Scientific Inc. – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-16: Thermo Fisher Scientific Inc. – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-17: Others – Japan IVD Sales (Million US$), 2015 – 2022
Figure 4-18: Others – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
List of Tables:
Table 2-1: By Segment – Japan IVD Market Share (Percent), 2008 – 2022
Table 2-2: By Segment – Forecast for Japan IVD Market Share (Percent), 2023 – 2028
Table 2-3: By Company – Japan IVD Market Share (Percent), 2015 – 2022
Table 2-4: By Company – Forecast for Japan IVD Market Share (Percent), 2023 – 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us